Literature DB >> 11522479

Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin.

D S Cox1, H Gao, S Raje, K R Scott, N D Eddington.   

Abstract

Zonula occludens toxin (Zot), a protein elaborated from Vibrio cholerae, has been shown to be capable of reversibly opening tight junctions between intestinal cells The objective of this study was to examine the effect of Zot on the flux of various molecules across Caco-2 cell monolayers. In addition, the transport of a series of anticonvulsants, the enaminones was also evaluated in the presence of Zot. The flux of [(14)C]mannitol, [(14)C]inulin and various enaminones across Caco-2 cell monolayers (n=6) was examined after pre-incubation for 1h with Zot (0 or 4000ng/ml) or phosphate-buffered saline (PBS). At the end of the incubation period, the flux of radiolabeled compounds or enaminones (1x10(-4)M) was assessed over a 2-h period. In addition, dose-response studies with Zot (0, 1000, 2000 or 4000ng/ml) were performed using mannitol. The flux of both mannitol and inulin significantly increased (P<0.05) in the presence of Zot. The transport of the enaminones with Zot ranged from 9.42 to 26.83x10(-5)cm/s vs. 4.68 to 13.83x10(-5)cm/s without Zot. Zot significantly increased the transport of all agents tested. This suggests that the co-administration of drugs with Zot may be a useful delivery strategy to increase the intestinal permeability and hence oral absorption of poorly bioavailable agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522479     DOI: 10.1016/s0939-6411(01)00172-2

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.

Authors:  Nusrat A Motlekar; Alessio Fasano; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2006-06       Impact factor: 5.121

2.  Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Authors:  Donna S Cox; Sangeeta Raje; Huanling Gao; Noha N Salama; Natalie D Eddington
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

3.  Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall.

Authors:  Alessio Fasano
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

4.  Ragweed pollen as an oral vaccine delivery system: Mechanistic insights.

Authors:  Md Jasim Uddin; Harvinder Singh Gill
Journal:  J Control Release       Date:  2017-10-17       Impact factor: 9.776

5.  QSAR study and molecular design of open-chain enaminones as anticonvulsant agents.

Authors:  Juan C Garro Martinez; Pablo R Duchowicz; Mario R Estrada; Graciela N Zamarbide; Eduardo A Castro
Journal:  Int J Mol Sci       Date:  2011-12-14       Impact factor: 5.923

6.  Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.

Authors:  Keon-Hyoung Song; Sang-Bum Kim; Chang-Koo Shim; Suk-Jae Chung; Dae-Duk Kim; Sang-Ki Rhee; Guang J Choi; Chul-Hyun Kim; Kiyoung Kim
Journal:  Drug Des Devel Ther       Date:  2015-03-27       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.